A phase I dose-escalation study of MEDI-575, a PDGFRα...

Cancer Chemotherapy and Pharmacology 2014 / 11 Vol. 74; Iss. 5

A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors

Becerra, Carlos R., Conkling, Paul, Vogelzang, Nicholas, Wu, Hilary, Hong, Shengyan, Narwal, Rajesh, Liang, Meina, Tavakkoli, Fatemeh, Pandya, Naimish
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
74
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2567-9
Date:
November, 2014
File:
PDF, 334 KB
english, 2014
Conversion to is in progress
Conversion to is failed